Author
jojolilimomo
View
229
Download
0
Embed Size (px)
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
1/58
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
2/58
EPIDEMIOLOGY2 MILLION VENOUS THROMBOTIC EVENTS OR VTE500,000 ARE DEEP VEIN THROMBOSIS
200,000 PULMONARY EMBOLISM
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
3/58
OVER 150 YEARS, VIRCHOW POSTULATEDTHAT THROMBUS FORMATION ANDPROPAGATION RESULTED FROM
ABNORMALITIESBLOOD FLOWVESSEL WALLBLOOD COMPONENTS
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
4/58
1. BLOOD FLOW- VENOUS STASISABNORMALITIES OF HAEMOORHEOLOGY ANDTURBULENCE AT VESSEL BIFURCATIONS AND
STENOTIC REGIONS
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
5/58
2. Vessel walls- impaired function of vesselwallAbnormalities in the endothelium, such as
atherosclerosis, and associated vascularinflammation
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
6/58
3.Blood components- changes in bloodconstituentsAbnormalities in coagulation and fibrinolytic
pathways
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
7/58
Initiated by action of tissue factor (TF) inFactor VII after injury to vessels exposes thesubendothelium and promotes platelet
adhesion and aggregation to forma primaryplatelet plug
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
8/58
The process is completed by actions of multiple components and factors in the bloodthat generate thrombin, potent rate-
regulating enzyme, which interacts withfibrinogen and Factor XIII to form aninsoluble clot
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
9/58
Malignancies, sustain venous damage(surgical procedure) there is up regulation of thrombin. TF, fibrin and thrombin have
angiogenic properties that can interfere withtissue properties by degrading matrixmetalloproteinases, promoting cell migrationand enhancing metastasis.
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
10/58
Tumors up regulate the production of TF andplasminogen activator inhibitor-1 (PAI-1)again promoting generation of procoagulant
activity
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
11/58
In addition to postsurgical reactions, there isincrease in fibrinogen, Factor V, Factor VIII,and Von Willebrand factor which promote
platelet adhesion and function
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
12/58
Increases platelet number, normalfibrinolytic response is blunted by theincrease PAI-1 and thrombin, activable
fibrinolysis inhibitor (TAFI)
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
13/58
Fibrinolytic system is non-functionalfollowing surgeryPreventings degradation of fibrin
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
14/58
Venous stasis is the cornerstone of postoperative thrombosisResults to platelet activation, promotingadhesions of platelets to endothelial cellslining the vessel, stressed to procoagulantmodeThese encourage the development of athrombus
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
15/58
The most common type of VTE is DVTDVT is the formation of a blood clot in adeep vein, usually in a calf or thigh muscle
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
16/58
Venous return from the lower extremity isdecreased by half during surgical proceduresbecause of the impact of muscle relaxationfrom anesthetic agentsLower extremity blood flow has been shownto decrease to about 75% of the normaldrainage flow immediately after surgery
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
17/58
This is an important reflection of virchows triad on the role of adequate vessel flow.This reduction in flow persists for about 14
days after surgery because of the loss of muscl pumping function in the legs
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
18/58
The major site of thrombus formation is thesoleal venous sinuses of the calf
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
19/58
Another contributing factor to venous stasisduring prolonged surgery is the use of tightpacking of the intestines in the upperabdomen with obstruction of the underlyingvena cava
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
20/58
Thrombus/ clot embolizes to the lungsMild PE, could be asymptomatic, or severeenough to cause an immediate cardiac attack
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
21/58
AGE >40 YEARS OLDOBESITY >20% ABOVE IDEAL WEIGHTPROLONGED SURGERY
IMMOBILITY (PRE-, PERI-, POST OPERAITVE)PELVIC MALIGNANCYPRIOR VTE
TRAUMA
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
22/58
THOMBOPHILIADIABETESHEART FAILURE
PRIOR RADIATIONCHRONIC OBSTRUCTIVE PULMONARY DISEASEVARICOSE VEINSSEPSIS
ACUTE INFLAMMATORY DISEASE WITHIMMOBILIZATIOI\N
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
23/58
Molecular Hypercoagulable stateDeficiency anti thrombinProtein C
Protein SHeparin cofactor IIFactor V LeidenProthrombin variant 20210A
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
24/58
Antiphopholipid antibodiesLupus anticoagulantAnticardiolipin
HyperhomocystinuriaDysfibrinogenemiaDec plasminogenDec Plasminogen activatorsHeparin-induced thrombocytopenia
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
25/58
PregnancyEstrogen therapy (OCP)Inflammatory bowel disease
Nephrotic syndromeHyperviscosity
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
26/58
Classically = calf pain, tenderness, swelling,redness and Homans sign Overall sens/spec = 3-91% Unreliable for diagnostic decisions Up to 50% have none of these
Wells developed and tested a clinicalprediction model for DVT
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
27/58
Swelling in one or both legsPain or tendernessWarmth in the skin of the affected leg
Red or discolored skinVisible surface veinsLeg fatigue
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
28/58
Dyspnea, pleuritic pain and cough mostcommon symptoms
Tachypnea, rales and tachycardia mostcommon signs
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
29/58
PE Assign Pretest Probability
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
30/58
The following were assigned a point valueof 1 if present
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
31/58
Paralysis or plaster immobilization Bedrest > 3 d or surgery in past 4 wks Localized tenderness
Entire leg swollen Calf > 3cm larger than unaffected leg Pitting edema greater than unaffected leg Collateral superficial veins
Alternative diagnosis more likely than DVT = - 2 points Probability High ( 3), Moderate (1-2) or Low (0 or less) DVT risk: High 75%, Moderate 17%, Low 3%
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
32/58
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
33/58
Single most important step in the diagnosisof pulmonary embolismMay be done based on clinical judgment oraided by a clinical scoring system
Modified Wells Criteria is the most widelyused and studiedReliably stratifies patients by likelihood of PEto allow selection of safe (
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
34/58
33 year old, female4 major surgeries due to intestinalobstruction
Prolonged surgeryImmobilization post-operativePost blood transfusion
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
35/58
Signs and symptomsOn and off low grade fever of unknown originUpper extremity pain and edema on the left, 7 th post operative daySudden onset of cough, chest pain, dyspneatachycardia
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
36/58
EKG- arrythmiaCXR -
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
37/58
Drug feverThrombophlebitis
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
38/58
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
39/58
I125 labeled Fibrinogen scanning
It involves the intravenous injections of isotope-
labeled fibrinogen, which is expected to beincorporated into the evolving thrombus and can beimaged by a scintillation scanner. Because of the useof isotopes, it is technically cumbersome and rarelyused, despite many large studies
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
40/58
Impedance Plethysmographybased on the principal of electricalresistance in specific areas of the body.
When there is resistance to blood flow that isdue to a thrombus, there is markedreduction in the electrical resistance overthat vessel.
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
41/58
Doppler UltrasoundDoppler ultrasound, often with computer colorenhancementmeasurement of flow velocity in larger blood vessels.
In this technique, a reflected sound signal isconverted to both an audible form and visual imageon a computer screen. In the presence of athrombosis, there is a decrease in the reflectedsignal that can be heard or, more likely, can bevisualized.
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
42/58
Real-Time UltrasoundCompression UltrasoundDuplex Doppler Ultrasound
real-time and Doppler methods in a procedureknown as B modevisualize the vessel and identify any thrombus init
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
43/58
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
44/58
Light Reflection RheographyRadioisotope ImagingIndirect Computed Tomography Venography
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
45/58
Magnetic Resonance Imaging/MagneticResonance Imaging Venography
differences in signal intensities to distinguishflowing blood from stagnant blood
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
46/58
Nonimaging Methodsautomated quantitative D-dimer assay
Blood test to measure fibrin degradationfragments generated by fibrinolysisIndicates thrombotic processUsed as an adjunct to non-invasive testing
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
47/58
Sensitive d-dimer testing can rule out DVTin low-moderate risk patients
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
48/58
With symptoms of DVTPositive D Dimer
http://www.ualberta.ca/~cw9/images/ddimer.jpg7/28/2019 DEEP VEIN THROMBOSIS let.pptx
49/58
3 GoalsTo prevent PEHalt further thrombus formationDissolve existing thrombus
Cornerstone of DVTDose adjusted IV unfractionated heparin
which preventsbformation of new thrombi
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
50/58
Bolus dose of heparin: 5000-10000 U EVInitial maintenance dose of heparin: 32000 UEV per 24h by continuous
infusion or 17000 U subcutaneously to berepeated after adjustment at 12h
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
51/58
Adjust dose of heparin at 6h according tonormogram.Maintain aPTT 2 times the control
Repeat aPTT 6 times every hour until intherapeutic range and thendaily (see nomogram)Start warfarin 10mg at 24h and 10mg next
day.
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
52/58
Overlap heparin and warfarin for at least 4daysPerform PT daily and adjust warfarin dose tomaintain INR at 2.0-3.0Continue heparin for a minimum of 5 days,then stop if INR has been intherapeutic range for at least 2 consecutive
days.
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
53/58
Continue warfarin for 3 months and monitorPT daily until in therapeuticrange, then 3 times during first week, twiceweekly for 2 weeks , or until
dose response is stable, and then every 2weeksObtain pretreatment hemoglobin level,platelet count, PT, and aPTT.
Repeat platelet count daily until heparinstopped.
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
54/58
Low Risk> Hospitalized medical patients without
risk factors
> Surgical patients under age 40, surgerylasting < 30 minutes, no additional riskfactors
Ambulatory leg exercises
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
55/58
Moderate risk >Hospitalized medical patientswith one or more risk factors>>Low dose heparin
>Surgical patients over age 40 having abdominalor thoracic surgery lasting > 30 minutes>>Low-dose heparin
> Neurosurgery or others patients with highbledding risk-Intermittent pneumaticcompression odf legs
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
56/58
High risk Hip fracture >> Warfarin(low dose regimen)Hip replacement
>Warfarin(low dose regimen) or LMWH Kneereplacement >>Warfarin(low dose regimen) andintermittent pneumatic compression of the legsGynecology Malignancy Intermittent pneumaticcompression of legs
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
57/58
Bleeding
7/28/2019 DEEP VEIN THROMBOSIS let.pptx
58/58